Dilantin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Dilantin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DILANTIN DESCRIPTION



Dilantin



CLINICAL PHARMACOLOGY









INDICATIONS & USAGE

DOSAGE AND ADMINISTRATIONCLINICAL PHARMACOLOGY

DILANTIN CONTRAINDICATIONS



WARNINGS

Effects of Abrupt Withdrawal


Suicidal Behavior and Ideation







IndicationPlacebo Patients with Events Per 1000 PatientsDrug Patients with Events Per 1000 PatientsRelative Risk: Incidence of Events in Drug Patients/Incidence in Placebo PatientsRisk Difference: Additional Drug Patients with Events Per 1000 Patients



Lymphadenopathy



Effects of Alcohol Use on Phenytoin Serum Levels


Exacerbation of Porphyria


Usage in Pregnancy

Clinical

PRECAUTIONS, Laboratory Tests









Preclinical


Skin reactions
WARNINGS


Anticonvulsant Hypersensitivity Syndrome



PRECAUTIONS

General


WARNINGS
WARNINGSADVERSE REACTIONS
CONTRAINDICATIONS




WARNINGS

INFORMATION FOR PATIENTS







PRECAUTIONS: Pregnancy

LABORATORY TESTS



DRUG INTERACTIONS







Drug Enteral Feeding/Nutritional Preparations Interaction


DRUG & OR LABORATORY TEST INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

WARNINGS

PREGNANCY

WARNINGS


NURSING MOTHERS



PEDIATRIC USE

DOSAGE AND ADMINISTRATION

DILANTIN ADVERSE REACTIONS

Body as a whole


Central Nervous System




Gastrointestinal System


Integumentary System
PRECAUTIONSWARNINGS

Hemopoietic System
WARNINGS

Connective Tissue System


Immunologic
WARNINGS

Musculoskeletal System


Special Senses


OVERDOSAGE




Treatment





DOSAGE & ADMINISTRATION




General




Adult Dosage


Pediatric Dosage


HOW SUPPLIED





STORAGE AND HANDLING









SPL MEDGUIDE












  • ●          thoughts about suicide or dying
  • ●          attempts to commit suicide
  • ●          new or worse depression
  • ●          new or worse anxiety
  • ●          feeling agitated or restless
  • ●          panic attacks
  • ●          trouble sleeping (insomnia)
  • ●          new or worse irritability
  • ●          acting aggressive, being angry, or violent
  • ●          acting on dangerous impulses
  • ●          an extreme increase activity and talking (mania)
  • ●          other unusual changes in behavior or mood

  • ●     Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings.
  • ●     Keep all follow-up visits with your healthcare provider as scheduled.


  • ●     Stopping DILANTIN suddenly can cause serious problems. Stopping a seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).



  • ●          If you take DILANTIN during pregnancy, your baby is at risk for serious birth defects.
  • ●          Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors
  • ●          If you take DILANTIN during pregnancy, your baby is also at risk for bleeding problems right after birth. Your healthcare provider may give you and your baby medicine to prevent this.
  • ●          All women of child-bearing age should talk to their healthcare provider about using other possible treatments instead of DILANTIN. If the decision is made to use DILANTIN, you should use effective birth control (contraception) unless you are planning to become pregnant.
  • ●          Tell your healthcare provider right away if you become pregnant while taking DILANTIN. You and your healthcare provider should decide if you will take DILANTIN while you are pregnant.
  • ●          Pregnancy Registry: If you become pregnant while taking DILANTIN, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can enroll in this registry by calling 1-888-233-2334. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.




  • ●          swelling of your face, eyes, lips, or tongue
  • ●          trouble swallowing or breathing
  • ●          a skin rash
  • ●          hives
  • ●          fever, swollen glands, or sore throat that do not go away or come and go
  • ●          painful sores in the mouth or around your eyes
  • ●          yellowing of your skin or eyes
  • ●          unusual bruising or bleeding
  • ●          severe fatigue or weakness
  • ●          severe muscle pain
  • ●          frequent infections or an infection that does not go away





  • ●     are allergic to phenytoin or any of the ingredients in DILANTIN. See the end of this leaflet for a complete list of ingredients in DILANTIN.
  • ●     have had an allergic reaction to CEREBYX (fosphenytoin), PEGANONE (ethotoin), or MESANTOIN (mephenytoin).


  • ●     Have or had liver disease
  • ●     Have or had porphyria
  • ●     Have or had diabetes
  • ●     Have or have had depression, mood problems, or suicidal thoughts or behavior
  • ●     Are pregnant or plan to become pregnant.
  • ●               If you become pregnant while taking DILANTIN, the level of DILANTIN in your blood may decrease, causing your seizures to become worse. Your healthcare provider may change your dose of DILANTIN.
  • ●     Are breast feeding or plan to breastfeed. DILANTIN can pass into breast milk. You and your healthcare provider should decide if you will take DILANTIN or breastfeed. You should not do both.




  • ●     Take DILANTIN exactly as prescribed. Your healthcare provider will tell you how much DILANTIN to take.
  • ●     Your healthcare provider may change your dose. Do not change your dose of DILANTIN without talking to your healthcare provider.
  • ●     DILANTIN can cause overgrowth of your gums. Brushing and flossing your teeth and seeing a dentist regularly while taking DILANTIN can help prevent this.
  • ●     If you take too much DILANTIN, call your healthcare provider or local Poison Control Center right away.
  • ●     Do not stop taking DILANTIN without first talking to your healthcare provider. Stopping DILANTIN suddenly can cause serious problems.




What is the most important information I should know about DILANTIN?

  • ●     Softening of your bones (osteomalacia). This can cause broken bones.


  • ●     problems with walking and coordination
  • ●     slurred speech
  • ●     confusion
  • ●     dizziness
  • ●     trouble sleeping
  • ●     nervousness
  • ●     tremor
  • ●     headache
  • ●     nausea
  • ●     vomiting
  • ●     constipation
  • ●     rash




  • ●     Store DILANTIN-125 Suspension at room temperature between 68to 77(20to 25Protect from light. Do not freeze.
  • ●     Store DILANTIN INFATABS at room temperature between 68to 77(20to 25Protect from moisture.
  • ●     Store DILANTIN Capsules at room temperature between 68to 77(20to 25in tight, light-resistant containers. Protect from moisture.






















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Dilantin

Dilantin

Dilantin

PHENYTOIN TABLET, CHEWABLE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-495(NDC:0071-0007)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PHENYTOIN Phenytoin 50 mg

Inactive Ingredients

Ingredient Name Strength
D&C YELLOW NO. 10
FD&C YELLOW NO. 6
ALUMINUM OXIDE
talc
saccharin sodium
SUCROSE

Product Characteristics

Color Size Imprint Code Shape
yellow 12 mm PD;007 TRIANGLE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-495-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA084427 2011-08-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.